Prevención y tratamiento de las infecciones del sitio operatorio en neurocirugía. Estado del arte

Palabras clave: Infección de la Herida Quirúrgica, Infecciones del Sistema Nervioso Central, Prevención de Enfermedades, Procedimientos Neuroquirúrgicos, Profilaxis Antibiótica, Terapéutica, Traumatismos Craneoencefálicos

Resumen

El manejo adecuado de las infecciones del sitio operatorio (ISO) en neurocirugía es fundamental para la disminución de la carga de morbilidad y mortalidad en estos pacientes. La sospecha y confirmación diagnóstica asociadas al aislamiento microbiológico son esenciales para asegurar el tratamiento oportuno y el adecuado gerenciamiento de antibióticos. En esta revisión se presenta de forma resumida los puntos fundamentales para la prevención y el tratamiento de infecciones del sitio operatorio en neurocirugía y se incluye un apartado sobre el uso de antibióticos intratecales/intraventriculares.

|Resumen
= 381 veces | PDF
= 306 veces|

Descargas

La descarga de datos todavía no está disponible.

Biografía del autor/a

Julio César García-Casallas, Universidad de La Sabana

Director de programa Facultad de Medicina, Director de departamento Farmacología clínica.

Jhósep Andrés Blanco-Mejía, Hospital Manuel Elkin Patarroyo. Inírida-Guainía

Médico general

Yuli Viviana Fuentes- Barreiro, Fundación Santa Fe de Bogotá

Médico general, Grupo de Investigación en Cirugía de Columna

Laura Camila Arciniegas-Mayorga, Hospital San Vicente de Paúl. Nemocón-Cundinamarca

Médico general

César Daniel Arias-Cepeda, Hospital San Antonio de Sesquilé. Sesquilé-Cundinamarca

Médico general

Brayan David Morales-Pardo, Hospital San José de Guaduas. Guaduas-Cundinamarca

Médico general

Citas

(1.) Herwaldt LA, Cullen JJ, Scholz D, French P, Zimmerman MB, Pfaller MA, et al. A prospective study of outcomes, healthcare resource utilization, and costs associated with postoperative nosocomial infections. Infect Control Hosp Epidemiol. 2006;27(12):1291-8. DOI 10.1086/509827.

(2.) McGirt MJ, Godil SS. Reduction of surgical site infection in spine surgery: an opportunity for quality improvement and cost reduction. Spine J. 2013;13(9):1030-1. DOI 10.1016/j.spinee.2013.06.003.

(3.) O’Keeffe AB, Lawrence T, Bojanic S. Oxford craniotomy infections database: a cost analysis of craniotomy infection. Br J Neurosurg. 2012;26(2):265-9. DOI 10.3109/02688697.2011.626878.

(4.) Saavedra CH, Ordonez KM, Diaz JA. [Nosocomial infections impact in a hospital in Bogota, Colombia: effects on mortality and hospital costs]. Rev Chilena Infectol. 2015;32(1):25-9. DOI 10.4067/S0716-10182015000200006.

(5.) Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, et al. Implementing an Antibiotic Stewardship Pro spp spp : Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):e51-77. DOI 10.1093/cid/ciw118.

(6.) Fajardo Rodríguez HA, Quemba Gordillo J, Eslava Schmalbach J. [Prediction scales and infection on

surgical sites in 15625 surgeries. 2001-2003]. Rev Salud Publica (Bogota). 2005;7(1):89-98.

(7.) Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Michael Scheld W, et al. 2017 Infectious Diseases Society of America’s Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis. Clin Infect Dis. 2017. DOI 10.1093/cid/ciw861.

(8.) Álvarez-Moreno C, Perez-Fernandez AM, Rosenthal VD, Quintero J, Chapeta-Parada E, Linares C, et al. Surgical site infection rates in 4 cities in Colombia: findings of the International Nosocomial Infection Control Consortium (INICC). Am J Infect Control. 2014;42(10):1089-92. DOI 10.1016/j.ajic.2014.06.010.

(9.) Edwards JR, Peterson KD, Mu Y, Banerjee S, Allen-Bridson K, Morrell G, et al. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control. 2009;37(10):783-805. DOI 10.1016/j.ajic.2009.10.001.

(10.) Gerometta A, Rodriguez Olaverri JC, Bitan F. Infections in spinal instrumentation. International orthopaedics. Int Orthop. 2012;36(2):457-64. DOI 10.1007/s00264-011-1426-0.

(11.) Governale LS, Fein N, Logsdon J, Black PM. Techniques and complications of external lumbar drainage for normal pressure hydrocephalus. Neurosurgery. 2008;63(4 Suppl 2):379-84;379-84. DOI 10.1227/01.NEU.0000327023.18220.88.

(12.) Lozier AP, Sciacca RR, Romagnoli MF, Connolly ES. Ventriculostomy-related Infections: A Critical Review of the Literature. Neurosurgery. 2002;51(1):170-82.

(13.) McClelland S, 3rd. Postoperative intracranial neurosurgery infection rates in North America versus Europe: a systematic analysis. Am J Infect Control. 2008;36(8):570-3. DOI 10.1016/j.ajic.2007.07.015.

(14.) Radcliff KE, Neusner AD, Millhouse PW, Harrop JD, Kepler CK, Rasouli MR, et al. What is new in the diagnosis and prevention of spine surgical site infections. Spine J. 2015;15(2):336-47. DOI 10.1016/j.spinee.2014.09.022.

(15.) Ramanan M, Lipman J, Shorr A, Shankar A. A metaanalysis of ventriculostomy-associated cerebrospinal fluid infections. BMC Infect Dis. 2015;15:3. DOI 10.1186/s12879-014-0712-z.

(16.) Rosenthal VD, Richtmann R, Singh S, Apisarnthanarak A, Kubler A, Viet-Hung N, et al. Surgical site infections, International Nosocomial Infection Control Consortium (INICC) report, data summary of 30 countries, 2005-2010. Infect Control Hosp Epidemiol. 2013;34(6):597-604. DOI 10.1086/670626.

(17.) Kourbeti IS, Vakis AF, Ziakas P, Karabetsos D, Potolidis E, Christou S, et al. Infections in patients undergoing craniotomy: risk factors associated with post-craniotomy meningitis. J Neurosurg. 2015;122(5):1113-9. DOI 10.3171/2014.8.JNS132557.

(18.) Ploegmakers IB, Olde Damink SW, Breukink SO. Alternatives to antibiotics for prevention of surgical infection. Br J Surg. 2017;104(2):e24-e33. DOI 10.1002/bjs.10426.

(19.) Seicean A, Kumar P, Seicean S, Neuhauser D, Selman WR, Bambakidis NC. Impact of Resident Involvement in Neurosurgery: An American College of Surgeons’ National Surgical Quality Improvement Program Database Analysis of 33,977 Patients. Neurospine. 2018;15(1):54-65. DOI 10.14245/ns.1836008.004.

(20.) Sarmey N, Kshettry VR, Shriver MF, Habboub G, Machado AG, Weil RJ. Evidence-based interventions to reduce shunt infections: a systematic review. Childs Nerv Syst. 2015;31(4):541-9. DOI 10.1007/s00381-015-2637-2.

(21.) Hill M, Baker G, Carter D, Henman LJ, Marshall K, Mohn K, et al. A multidisciplinary approach to end external ventricular drain infections in the neurocritical care unit. J Neurosci Nurs. 2012;44(4):188-93. DOI 10.1097/JNN.0b013e3182527672.

(22.) Kestle JR, Riva-Cambrin J, Wellons JC, 3rd, Kulkarni AV, Whitehead WE, Walker ML, et al. A standardized protocol to reduce cerebrospinal fluid shunt infection: the Hydrocephalus Clinical Research Network Quality Improvement Initiative. J Neurosurg Pediatr. 2011;8(1):22-9. DOI 10.3171/2011.4.PEDS10551.

(23.) Rivero-Garvia M, Marquez-Rivas J, Jimenez-Mejias ME, Neth O, Rueda-Torres AB. Reduction in external ventricular drain infection rate. Impact of a minimal handling protocol and antibiotic-impregnated catheters. Acta Neurochir (Wien). 2011;153(3):647-51. DOI 10.1007/s00701-010-0905-1.

(24.) Rozzelle CJ, Leonardo J, Li V. Antimicrobial suture wound closure for cerebrospinal fluid shunt surgery: a prospective, double-blinded, randomized controlled trial. J Neurosurg Pediatr. 2008;2(2):111-7. DOI 10.3171/PED/2008/2/8/111.

(25.) Govender ST, Nathoo N, van Dellen JR. Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus. J Neurosurg. 2003;99(5):831-9. DOI 10.3171/jns.2003.99.5.0831.

(26.) Harrop JS, Sharan AD, Ratliff J, Prasad S, Jabbour P, Evans JJ, et al. Impact of a standardized protocol and antibiotic-impregnated catheters on ventriculostomy infection rates in cerebrovascular patients. Neurosurgery. 2010;67(1):187-91. DOI 10.1227/01. NEU.0000370247.11479.B6.

(27.) Konstantelias AA, Vardakas KZ, Polyzos KA, Tansarli GS, Falagas ME. Antimicrobial-impregnated and-coated shunt catheters for prevention of infections in patients with hydrocephalus: a systematic review and meta-analysis. J Neurosurg. 2015;122(5):1096-112. DOI 10.3171/2014.12.JNS14908.

(28.) Parker SL, Anderson WN, Lilienfeld S, Megerian JT, McGirt MJ. Cerebrospinal shunt infection in patients receiving antibiotic-impregnated versus standard shunts. Journal of neurosurgery Pediatrics. 2011;8(3):259-65.

(29.) Parker SL, McGirt MJ, Murphy JA, Megerian JT, Stout M, Engelhart L. Comparative effectiveness of antibioticimpregnated shunt catheters in the treatment of adult and pediatric hydrocephalus: analysis of 12,589 consecutive cases from 287 US hospital systems. J Neurosurg. 2015;122(2):443-8. DOI 10.3171/2014.10.JNS13395.

(30.) Root BK, Barrena BG, Mackenzie TA, Bauer DF. Antibiotic Impregnated External Ventricular Drains: Meta and Cost Analysis. World Neurosurg. 2016;86:306-15. DOI 10.1016/j.wneu.2015.09.032.

(31.) Sonabend AM, Korenfeld Y, Crisman C, Badjatia N, Mayer SA, Connolly ES Jr. Prevention of ventriculostomy-related infections with prophylactic antibiotics and antibiotic-coated external ventricular drains: a systematic review. Neurosurgery. 2011;68(4):996-1005. DOI 10.1227/NEU.0b013e3182096d84.

(32.) Tamburrini G, Massimi L, Caldarelli M, Di Rocco C. Antibiotic impregnated external ventricular drainage and third ventriculostomy in the management of hydrocephalus associated with posterior cranial fossa tumours. Acta Neurochir (Wien). 2008;150(10):1049-55. DOI 10.1007/s00701-008-0022-6.

(33.) Thomas R, Lee S, Patole S, Rao S. Antibiotic-impregnated catheters for the prevention of CSF shunt infections: a systematic review and metaanalysis. Br J Neurosurg. 2012;26(2):175-84. DOI

3109/02688697.2011.603856.

(34.) Kan P, Kestle J. Lack of efficacy of antibiotic-impregnated shunt systems in preventing shunt infections in children. Childs Nerv Syst. 2007;23(7):773-7. DOI 10.1007/s00381-007-0296-7.

(35.) Ritz R, Roser F, Morgalla M, Dietz K, Tatagiba M, Will BE. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients. BMC Infect Dis. 2007;7:38. DOI 10.1186/1471-2334-7-38.

(36.) McLaughlin N, St-Antoine P, Bojanowski MW. Impact of antibiotic-impregnated catheters on the timing of cerebrospinal fluid infections in non-traumatic subarachnoid hemorrhage. Acta Neurochir (Wien). 2012;154(4):761-7. DOI 10.1007/s00701-012-1276-6.

(37.) Sciubba DM, McGirt MJ, Woodworth GF, Carson B, Jallo GI. Prolonged exposure to antibiotic-impregnated shunt catheters does not increase incidence of late shunt infections. Childs Nerv Syst. 2007;23(8):867-71. DOI 10.1007/s00381-007-0334-5.

(38.) Wong GKC, Poon WS, Stephanie CPN, Ip M. The impact of ventricular catheter impregnated with antimicrobial agents on infections in patients with ventricular catheter: interim report. Acta Neurochir Suppl. 2008;102:53-5. DOI 10.1007/978-3-211-85578-2_11.

(39.) Murphy RK, Liu B, Srinath A, Reynolds MR, Liu J, Craighead MC, et al. No additional protection against ventriculitis with prolonged systemic antibiotic prophylaxis for patients treated with antibioticcoated external ventricular drains. J Neurosurg. 2015;122(5):1120-6. DOI 10.3171/2014.9.JNS132882.

(40.) Cui Z, Wang B, Zhong Z, Sun Y, Sun Q, Yang G, et al. Impact of antibiotic- and silver-impregnated external ventricular drains on the risk of infections: A systematic review and meta-analysis. Am J Infect Control. 2015;43(7):e23-32. DOI 10.1016/j.ajic.2015.03.015.

(41.) Burrows AM, Murphy ME, Daniels DJ, Meyer FB. Antibiotic Reservoir Injection Reduces Shunt Infection in Adults. World Neurosurg. 2016;89:108-11. DOI 10.1016/j.wneu.2016.01.077.

(42.) Ragel BT, Browd SR, Schmidt RH. Surgical shunt infection: significant reduction when using intraventricular and systemic antibiotic agents. J Neurosurg. 2006;105(2):242-7. DOI 10.3171/jns.2006.105.2.242.

(43.) Leib SL, Boscacci R, Gratzl O, Zimmerli W. Predictive value of cerebrospinal fluid (CSF) lactate level versus CSF/blood glucose ratio for the diagnosis of bacterial meningitis following neurosurgery. Clin Infect Dis. 1999;29(1):69-74. DOI 10.1086/520184.

(44.) Abraham P, Lamba N, Acosta M, Gholmie J, Dawood HY, Vestal M, et al. Antibacterial prophylaxis for gram-positive and gram-negative infections in cranial surgery: A meta-analysis. J Clin Neurosci. 2017;45:24-32. DOI 10.1016/j.jocn.2017.07.039.

(45.) Alotaibi AF, Hulou MM, Vestal M, Alkholifi F, Asgarzadeh M, Cote DJ, et al. The Efficacy of Antibacterial Prophylaxis Against the Development of Meningitis After Craniotomy: A Meta-Analysis. World Neurosurg. 2016;90:597-603 e1. DOI 10.1016/j.wneu.2016.02.048.

(46.) Haines S, Walters B. Antibiotic prophylaxis for cerebrospinal fluid shunts: a metanalysis. Neurosurgery. 1994;34(1):87-92.

(47.) Klimo P, Jr., Van Poppel M, Thompson CJ, Baird LC, Duhaime AC, Flannery AM, et al. Pediatric hydrocephalus: systematic literature review and evidence-based guidelines. Part 6: Preoperative antibiotics for shunt surgery in children with hydrocephalus: a systematic review and meta-analysis. J Neurosurg Pediatr. 2014;14(Suppl 1):44-52. DOI 10.3171/2014.7.PEDS14326.

(48.) Langley JM, LeBlanc JC, Drake J, Milner R. Efficacy of Antimicrobial Prophylaxis in Placement of Cerebrospinal Fluid Shunts: Meta-Analysis. Clin Infect Dis. 1993;17(1):98-103.

(49.) Ratilal B, Costa J, Sampaio C. Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts. Cochrane Database Syst Rev. 2006(3):CD005365. DOI 10.1002/14651858.CD005365.pub2.

(50.) Ratilal B, Costa J, Sampaio C. Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts: a systematic review. J Neurosurg Pediatr. 2008;1(1):48-56. DOI 10.3171/PED-08/01/048.

(51.) Xu H, Hu F, Hu H, Sun W, Jiao W, Li R, et al. Antibiotic prophylaxis for shunt surgery of children: a systematic review. Childs Nerv Syst. 2016;32(2):253-8. DOI 10.1007/s00381-015-2937-6.

(52.) Rosen SA, Getz AE, Kingdom T, Youssef AS, Ramakrishnan VR. Systematic review of the effectiveness of perioperative prophylactic antibiotics for skull base surgeries. Am J Rhinol Allergy. 2016;30(2):e10-6. DOI 10.2500/ajra.2016.30.4298.

(53.) Tacconelli E, Cataldo MA, Albanese A, Tumbarello M, Arduini E, Spanu T, et al. Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus. J Hosp Infect. 2008;69(4):337-44. DOI 10.1016/j.jhin.2008.04.032.

(54.) Nejat F, Tajik P, El Khashab M, Kazmi S, Khotaei G, Salahesh S. A randomized trial of ceftriaxone versus trimethoprim-sulfamethoxazole to prevent ventriculoperitoneal shunt infection. J Microbiol Immunol Infect. 2008;41(2):112-7.

(55.) Wong GK, Poon WS, Lyon D, Wai S. Cefepime vs. Ampicillin/Sulbactam and Aztreonam as antibiotic prophylaxis in neurosurgical patients with external ventricular drain: result of a prospective randomized controlled clinical trial. J Clin

Pharm Ther. 2006;31(3):231-5. DOI 10.1111/j.1365-2710.2006.00729.x.

(56.) Ghobrial GM, Cadotte DW, Williams K Jr, Fehlings MG, Harrop JS. Complications from the use of intrawound vancomycin in lumbar spinal surgery: a systematic review. Neurosurgical focus. 2015;39(4):E11. DOI 10.3171/2015.7.FOCUS15258.

(57.) Abdullah KG, Attiah MA, Olsen AS, Richardson A, Lucas TH. Reducing surgical site infections following craniotomy: examination of the use of topical vancomycin. J Neurosurg. 2015;123(6):1600-4. DOI 10.3171/2014.12.JNS142092.

(58.) Amrani J. Intraoperative powdered vancomycin use with paddle lead placement. Neuromodulation. 2015;18(3):177-80; discussion 181. DOI 10.1111/ner.12216.

(59.) Bakhsheshian J, Dahdaleh NS, Lam SK, Savage JW, Smith ZA. The use of vancomycin powder in modern spine surgery: systematic review and metaanalysis of the clinical evidence. World Neurosurg. 2015;83(5):816-23. DOI 10.1016/j.wneu.2014.12.033.

(60.) Hill BW, Emohare O, Song B, Davis R, Kang MM. The use of vancomycin powder reduces surgical reoperation in posterior instrumented and noninstrumented spinal surgery. Acta Neurochir (Wien). 2014;156(4):749-54. DOI 10.1007/s00701-014-2022-z.

(61.) Should we add vancomycin antibiotic powder to prevent post operative infection in spine surgery? - First update. Medwave. 2015;15(Suppl 1):e6160. DOI 10.5867/medwave.2015.6202.

(62.) López M, Molina M. Should we add vancomycin antibiotic powder to prevent post operative infection in spine surgery? - First update. Medwave. 2015;15 (Suppl 2):e6202.

(63.) Molinari RW, Khera OA, Molinari WJ 3rd. Prophylactic intraoperative powdered vancomycin and postoperative deep spinal wound infection: 1,512 consecutive surgical cases over a 6-year period. Eur Spine J. 2012;21(Suppl 4):S476-82. DOI 10.1007/s00586-011-2104-z.

(64.) Rasouli JJ, Kopell BH. The Adjunctive Use of Vancomycin Powder Appears Safe and May Reduce the Incidence of Surgical-Site Infections After Deep Brain Stimulation Surgery. World Neurosurg. 2016;95:9-13. DOI 10.1016/j.wneu.2016.07.063.

(65.) Ravikumar V, Ho AL, Pendhakar AV, Sussman ES, Kwong-Hon Chow K, Li G. The Use of Vancomycin Powder for Surgical Prophylaxis Following Craniotomy. Neurosurgery. 2017;80(5):754-8. DOI 10.1093/neuros/nyw127.

(66.) Strom RG, Pacione D, Kalhorn SP, Frempong-Boadu AK. Lumbar laminectomy and fusion with routine local application of vancomycin powder: decreased infection rate in instrumented and non-instrumented cases. Clin Neurol Neurosurg. 2013;115(9):1766-9. DOI 10.1016/j.clineuro.2013.04.005.

(67.) Tomov M, Mitsunaga L, Durbin-Johnson B, Nallur D, Roberto R. Reducing surgical site infection in spinal surgery with betadine irrigation and intrawound vancomycin powder. Spine (Phila Pa 1976). 2015;40(7):491-9. DOI 10.1097/BRS.0000000000000789.

(68.) van Lindert EJ, Bilsen MV, Flier MV, Kolwijck E, Delye H, Oever JT. Topical vancomycin reduces the cerebrospinal fluid shunt infection rate: A retrospective cohort study. PloS one. 2018;13(1):e0190249. DOI 10.1371/journal.pone.0190249.

(69.) Tubaki VR, Rajasekaran S, Shetty AP. Effects of using intravenous antibiotic only versus local intrawound vancomycin antibiotic powder application in addition to intravenous antibiotics on postoperative infection in spine surgery in 907 patients. Spine (Phila Pa 1976). 2013;38(25):2149-55. DOI 10.1097/BRS.0000000000000015.

(70.) Carney N, Totten AM, O’Reilly C, Ullman JS, Hawryluk GW, Bell MJ, et al. Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition. Neurosurgery. 2017;80(1):6-15. DOI 10.1227/ NEU.0000000000001432.

(71.) Poole D, Chieregato A, Langer M, Viaggi B, Cingolani E, Malacarne P, et al. Systematic review of the literature and evidence-based recommendations for antibiotic prophylaxis in trauma: results from an Italian consensus of experts. PLoS One. 2014;9(11):e113676. DOI 10.1371/journal.pone.0113676.

(72.) Eftekhar B, Ghodsi M, Nejat F, Ketabchi E, Esmaeeli B. Prophylactic administration of ceftriaxone for the prevention of meningitis after traumatic pneumocephalus: results of a clinical trial. J Neurosurg. 2004;101(5):757-61. DOI 10.3171/jns.2004.101.5.0757.

(73.) Fang C, Zhu T, Zhang P, Xia L, Sun C. Risk factors of neurosurgical site infection after craniotomy: A systematic review and meta-analysis. Am J Infect Control. 2017;45(11):e123-e34. DOI 10.1016/j.ajic.2017.06.009.

(74.) Fei Q, Li J, Lin J, Li D, Wang B, Meng H, et al. Risk Factors for Surgical Site Infection After Spinal Surgery: A Meta-Analysis. World Neurosurg. 2016;95:507-15. DOI 10.1016/j.wneu.2015.05.059.

(75.) Zyck S, Toshkezi G, Krishnamurthy S, Carter DA, Siddiqui A, Hazama A, et al. Treatment of Penetrating Nonmissile Traumatic Brain Injury. Case Series and Review of the Literature. World Neurosurg. 2016;91:297-307. DOI 10.1016/j.wneu.2016.04.012.

(76.) Lazennec JY, Fourniols E, Lenoir T, Aubry A, Pissonnier ML, Issartel B, et al. Infections in the operated spine: update on risk management and therapeutic strategies. Orthop Traumatol Surg Res. 2011;97(6 Suppl):S107-16. DOI 10.1016/j.otsr.2011.07.002.

(77.) Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis. 2014;59(2):147-59. DOI 10.1093/cid/ciu296.

(78.) Barker FG. Efficacy of Prophylactic Antibiotic Therapy in Spinal Surgery: A Meta-analysis. Neurosurgery. 2002;51(2):391-401.

(79.) Levi AD, Dickman CA, Sonntag VK. Management of postoperative infections after spinal instrumentation. J Neurosurg. 1997;86(6):975-80.

(80.) Massie J, Heller J, Abitbol J, McPherson D, Garfin S. Postoperative posterior spinal wound infections. Clin Orthop Relat Res 1992(284):99-108. DOI 10.3171/jns.1997.86.6.0975.

(81.) National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004;32(8):470-85. DOI 10.1016/S0196655304005425.

(82.) Olsen MA, Mayfield J, Lauryssen C, Polish L, al Jones M, Vest J. Risk factors for surgical site infection in spinal surgery. J Neurosurg. 2003;98(2):149-55. DOI 10.3171/spi.2003.98.2.0149.

(83.) Pawar AY, Biswas SK. Postoperative Spine Infections. Asian Spine J. 2016;10(1):176-83. DOI 10.4184/asj.2016.10.1.176.

(84.) Rechtine GR, Bono PL, Cahill D, Bolesta MJ, Chrin AM. Postoperative Wound Infection after Instrumentation of Thoracic and Lumbar Fractures. J Orthop Trauma. 2001;15(8):566-9.

(85.) Stolke D, Sollmann W, Seifert V. Intra- and postoperative complications in lumbar disc surgery. Spine (Phila Pa 1976) 1989;14(1):56-9.

(86.) Thalgott JS, Cotler HB, Sasso RC, LaRocca H, Gardner V. Postoperative Infections in Spinal Implants Classification and Analysis—A Multicenter Study. Spine. 1991;16(8):981-4.

(87.) Weinstein MA, McCabe JP, Cammisa FP. Postoperative Spinal Wound Infection: A Review of 2,391 Consecutive Index Procedures. J Spinal Disord. 2000;13(5):422-6.

(88.) Mitra A, Mitra A, Harlin S. Treatment of massive thoracolumbar wounds and vertebral osteomyelitis following scoliosis surgery. Plast Reconstr Surg. 2004;113(1):206-13.

(89.) Silber JS, Anderson DG, Vaccaro AR, Anderson PA, McCormick P, NASS. Management of postprocedural discitis. Spine J. 2002;2(4):279-87.

(90.) Pee YH, Park JD, Choi YG, Lee SH. Anterior debridement and fusion followed by posterior pedicle screw fixation in pyogenic spondylodiscitis: autologous iliac bone strut versus cage. J Neurosurg Spine. 2008;8(5):405-12. DOI 10.3171/SPI/2008/8/5/405.

(91.) Sierra-Hoffman M, Jinadatha C, Carpenter JL, Rahm M. Postoperative instrumented spine infections: a retrospective review. South Med J. 2010;103(1):25-30. DOI 10.1097/SMJ.0b013e3181c4e00b.

(92.) Weiss L, Vaccaro A, Scuderi G, McGuire M, Garfin S. Pseudarthrosis after postoperative wound infection in the lumbar spine. J Spinal Disord. 1997;10(6):482-7.

(93.) Gruenberg MF, Campaner GL, Sola CA, Ortolan EG. Ultraclean Air for Prevention of Postoperative infection after posterior spinal fusion with instrumentation. Spine. 2004;29(20):2330-4.

(94.) Viola R, King H, Adler S, Wilson C. Delayed infection after elective spinal instrumentation and fusion. A retrospective analysis of eight cases. Spine (Phila Pa1976). 1997;22:2444–50.

(95.) Watt JP, Dunn RN. The Use of Vacuum Dressings for Dead Space Management in Deep Surgical Site Infections Allows Implant and Bone Graft Retention. Global Spine J. 2017;7(8):756-61. DOI 10.1177/2192568217696694.

(96.) Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52(3):e18-55. DOI 10.1093/cid/ciq146.

(97.) Bryant M, Bremer A, Tepas Jr, Mollitt D, Nquyen T, Talbert J. Abdominal complications of ventriculoperitoneal shunts. Case reports and review of the literature. Am Surg. 1988;54:50–5.

(98.) Mayhall CG, Archer NH, Lamb VA, Spadora AC, Baggett JW, Ward JD, et al. Ventriculostomy-related infections. A prospective epidemiologic study. N Engl J Med. 1984;310(9):553-9. DOI 10.1056/NEJM198403013100903.

(99.) Odio C, McCracken GJ, Nelson J. CSF shunt infections in pediatrics. A seven- year experience. Am J Dis Child. 1984;138(12):1103–8.

(100.) Van de Beek D, Drake JM, Tunkel AR. Nosocomial bacterial meningitis. N Engl J Med. 2010;362(2):146-54. DOI 10.1056/NEJMra0804573.

(101.) Forgacs P, Geyer CA, Freidberg SR. Characterization of chemical meningitis after neurological surgery. Clin Infect Dis. 2001;32(2):179-85. DOI 10.1086/318471.

(102) Schade RP, Schinkel J, Roelandse FW, Geskus RB, Visser LG, van Dijk JM, et al. Lack of value of routine analysis of cerebrospinal fluid for prediction and diagnosis of external drainage-related bacterial meningitis. J Neurosurg. 2006;104(1):101-8. DOI 10.3171/jns.2006.104.1.101.

(103.) Xiao X, Zhang Y, Zhang L, Kang P, Ji N. The diagnostic value of cerebrospinal fluid lactate for post-neurosurgical bacterial meningitis: a meta-analysis. BMC Infect Dis. 2016;16:483. DOI 10.1186/s12879-016-1818-2.

(104.) Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39(9):1267-84. DOI 10.1086/425368.

(105.) Antony SJ, Hoffman-Roberts HL, Foote BS. Use of Daptomycin as Salvage Therapy in the Treatment of Central Nervous System Infections Including Meningitis and Shunt Infections. Infectious Diseases in Clinical Practice. 2012;20(2):161-3.

(106.) Dunne WM, Mason EO, Kaplan SL. Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm. Antimicrobial Agents and Chemotherapy. 1993;37(12):2522-6.

(107.) Gombert ME, Landesman SH, Corrado ML, Stein SC, Melvin ET, Cummings M. Vancomycin and rifampin therapy for Staphylococcus epidermidis meningitis associated with CSF shunts: report of three cases. J Neurosurg. 1981;55(4):633-6. DOI 10.3171/jns.1981.55.4.0633.

(108.) Groll AH, Giri N, Petraitis V, Petraitiene R, Candelario M, Bacher JS, et al. Comparative efficacy and distributionof lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system. J Infect Dis. 2000;182(1):274-82. DOI 10.1086/315643.

(109.) Kim B-N, Peleg AY, Lodise TP, Lipman J, Li J, Nation R, et al. Management of meningitis due to antibioticresistant Acinetobacter species. Lancet Infect Dis. 2009;9(4):245-55. DOI 10.1016/S1473-3099(09)70055-6.

(110.) Milstone AM, Dick J, Carson B, Siberry GK. Cerebrospinal fluid penetration and bacteriostatic activity of linezolid against Enterococcus faecalis in a child with a ventriculoperitoneal shunt infection. Pediatr Neurosurg. 2007;43(5):406-9. DOI 10.1159/000106392.

(111.) Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1-50. DOI 10.1093/cid/civ933.

(112.) Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63(4):e1-e60. DOI

1093/cid/ciw326.

(113.) ybak M, Lomaestro B, Rotschafer JC, Moellering R, Jr, Craig W, Billeter M, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009;66(1):82-98. DOI 10.2146/ajhp080434.

(114.) Yilmaz A, Dalgic N, Musluman M, Sancar M, Colak I, Aydin Y. Linezolid treatment of shunt-related cerebrospinal fluid infections in children. J Neurosurg Pediatr. 2010;5(5):443-8. DOI 10.3171/2009.12.PEDS09421.

(115.) Kestle JR, Garton HJ, Whitehead WE, Drake JM, Kulkarni AV, Cochrane DD, et al. Management of shunt infections: a multicenter pilot study. J Neurosurg. 2006;105(3 Suppl):177-81. DOI 10.3171/ped.2006.105.3.177.

(116.) James H, Walsh J, Wilson H, Connor J. The management of cerebrospinal fluid shunt infections: a clinical experience. Acta Neurochir (Wien). 1981;59:157–66.

(117.) Schreffler RT, Schreffler AJ, Wittler RR. Treatment of cerebrospinal fluid shunt infections: a decision analysis. Pediatr Infect Dis J. 2002;21(7):632-6. DOI 10.1097/01.inf.0000020964.43766.35.

(118.) Yogev R. Cerebrospinal fluid shunt infections: a personal view. Pediatr Infect Dis. 1985;4(2):113-8.

(119.) Whitehead WE, Kestle JR. The treatment of cerebrospinal fluid shunt infections. Results from a practice survey of the American Society of Pediatric Neurosurgeons. Pediatr Neurosurg. 2001;35(4):205-10. DOI 10.1159/000050422.

(120.) Chapman P, Borges L. Shunt infections: prevention and treatment. Clin Neurosurg. 1985;32:652–64.

(121.) Brown EM, Edwards RJ, Pople IK. Conservative management of patients with cerebrospinal fluid shunt infections. Neurosurgery. 2006;58(4):657-65; discussion-65. DOI 10.1227/01.NEU.0000204126.54417.46.

(122.) Brown J, de Louvois R, Bayston PD, Lees IK, Pople EM. The management of neurosurgical patients with postoperative bacterial or aseptic meningitis or external ventricular drain-associated ventriculitis. British journal of neurosurgery. 2009;14(1):7-12.

(123.) Tamber MS, Klimo P. Jr, Mazzola CA, Flannery AM, Pediatric Hydrocephalus Systematic R, Evidence-Based Guidelines Task F. Pediatric hydrocephalus: systematic literature review and evidence-based guidelines. Part 8: Management of cerebrospinal fluid shunt infection. J Neurosurg Pediatr. 2014;14 (Suppl 1:)60-71. DOI 10.3171/2014.7.PEDS14328.

(124.) Wen DY, Bottini AG, Hall WA, Haines SJ. Infections in neurologic surgery. The intraventricular use of antibiotics. Neurosurg Clin N Am. 1992;3:343–54. DOI 10.1016/S1042-3680(18)30666-1.

(125.) Wilkie MD, Hanson MF, Statham PF, Brennan PM. Infections of cerebrospinal fluid diversion devices in adults: the role of intraventricular antimicrobial therapy. J Infect. 2013;66(3):239-46. DOI 10.1016/j.jinf.2012.11.006.

(126.) Shah SS, Ohlsson A, Shah VS. Intraventricular antibiotics for bacterial meningitis in neonates. Cochrane Database Syst Rev. 2012(7):CD004496. DOI 10.1002/14651858.CD004496.pub3.

(127.) Fu RZ, Anwar DR, Laban JT, Maratos EC, Minhas PS, Martin AJ. Pre-emptive intrathecal vancomycin therapy reduces external ventricular drain infection: a single centre retrospective case-control study. Br J Neurosurg. 2017;31(1):16-20. DOI 10.1080/02688697.2016.1229741.

(128.) Chen K, Wu Y, Wang Q, Wang J, Li X, Zhao Z, et al. The methodology and pharmacokinetics study of intraventricular administration of vancomycin in patients with intracranial infections after craniotomy. J Crit Care. 2015;30(1):218 e1-5. DOI 10.1016/j.jcrc.2014.09.020.

(129.) Cook AM, Mieure KD, Owen RD, Pesaturo AB, Hatton J. Intracerebroventricular administration of drugs. Pharmacotherapy. 2009;29(7):832-45. DOI 10.1592/phco.29.7.832.

(130.) Grill MF, Maganti RK. Neurotoxic effects associated with antibiotic use: management considerations. Br J Clin Pharmacol. 2011;72(3):381-93. DOI 10.1111/j.1365-2125.2011.03991.x.

(131.) Imberti R, Cusato M, Accetta G, Marino V, Procaccio F, Del Gaudio A, et al. Pharmacokinetics of colistin in cerebrospinal fluid after intraventricular administration of colistin methanesulfonate. Antimicrob Agents Chemother. 2012;56(8):4416-21. DOI 10.1128/AAC.00231-12.

(132.) LeBras M, Chow I, Mabasa VH, Ensom MH. Systematic Review of Efficacy, Pharmacokinetics, and Administration of Intraventricular Aminoglycosides in Adults. Neurocrit Care. 2016;25(3):492-507. DOI

1007/s12028-016-0269-3.

(133.) Nau R, Seele J, Djukic M, Eiffert H. Pharmacokinetics and pharmacodynamics of antibiotics in central nervous system infections. Curr Opin Infect Dis. 2018;31(1):57-68. DOI 10.1097/QCO.0000000000000418.

(134.) Ng K, Mabasa VH, Chow I, Ensom MH. Systematic review of efficacy, pharmacokinetics, and administration of intraventricular vancomycin in adults. Neurocrit Care. 2014;20(1):158-71. DOI 10.1007/s12028-012-9784-z.

(135.) Pfausler B, Haring H, Kampfl A, Wissel J, Schober M, Schmutzhard E. Cerebrospinal fluid (CSF) pharmacokinetics of intraventricular vancomycin in patients with staphylococcal ventriculitis associated with external CSF drainage. Clin Infect Dis. 1997;25:733–5.

(136.) Cruciani M, Navarra A, Di Perri G, Andreoni M, Danzi M, Concia E. Evaluation of intraventricular teicoplanin for the treatment of neurosurgical shunt infections. Clin Infect Dis. 1992;15:285–9.

(137.) Elvy J, Porter D, Brown E. Treatment of external ventricular drain-associated ventriculitis caused by Enterococcus faecalis with intraventricular daptomycin. J Antimicrob Chemother. 2008;61(2):461-2. DOI 10.1093/jac/dkm501.

(138.) Erritouni M, Ktaich N, Rahal JJ, Figueroa D, Nieto J, Urban C, et al. Use of daptomycin for the treatment of methicillin-resistant coagulase-negative staphylococcal ventriculitis. Case Rep Med. 2012;2012:593578. DOI 10.1155/2012/593578.

(139.) Falagas ME, Bliziotis IA, Tam VH. Intraventricular or intrathecal use of polymyxins in patients with Gramnegative meningitis: a systematic review of the available evidence. Int J Antimicrob Agents. 2007;29(1):9-25. DOI 10.1016/j.ijantimicag.2006.08.024.

(140.) Jaspan HB, Brothers AW, Campbell AJ, McGuire JK, Browd SR, Manley TJ, et al. Multidrug-resistant Enterococcus faecium meningitis in a toddler: characterization of the organism and successful treatment with intraventricular daptomycin and intravenous tigecycline. Pediatr Infect Dis J. 2010;29(4):379-81. DOI 10.1097/INF.0b013e3181c806d8.

(141.) Katragkou A, Roilides E. Successful treatment of multidrug-resistant Acinetobacter baumannii central nervous system infections with colistin. J Clin Microbiol. 2005;43(9):4916-7. DOI 10.1128/JCM.43.9.4916-4917.2005.

(142.) Mueller SW, Kiser TH, Anderson TA, Neumann RT. Intraventricular daptomycin and intravenous linezolid for the treatment of external ventriculardrain-associated ventriculitis due to vancomycinresistant Enterococcus faecium. Ann Pharmacother. 2012;46(12):e35. DOI 10.1345/aph.1R412.

(143.) Pfausler B, Spiss H, Beer R, Kampl A, Engelhardt K, Schober M, et al. Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of

intravenous compared with intraventricular vancomycin therapy. J Neurosurg. 2003;98(5):1040-4. DOI 10.3171/jns.2003.98.5.1040.

(144.) Rodriguez Guardado A, Blanco A, Asensi V, Perez F, Rial JC, Pintado V, et al. Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments. J Antimicrob Chemother. 2008;61(4):908-13. DOI 10.1093/jac/dkn018.

(145.) Tangden T, Enblad P, Ullberg M, Sjolin J. Neurosurgical gram-negative bacillary ventriculitis and meningitis: a retrospective study evaluating the efficacy of intraventricular gentamicin therapy in 31 consecutive cases. Clin Infect Dis. 2011;52(11):1310-6. DOI

1093/cid/cir197.

(146.) Wang JH, Lin PC, Chou CH, Ho CM, Lin KH, Tsai CT, et al. Intraventricular antimicrobial therapy in postneurosurgical Gram-negative bacillary meningitis or ventriculitis: a hospital-based retrospective study. J Microbiol Immunol Infect. 2014;47(3):204-10. DOI 10.1016/j.jmii.2012.08.028.

(147.) Williamson JC, Glazier SS, Peacock JE. Successful treatment of ventriculostomy-related meningitis caused by vancomycin-resistant Enterococcus with intravenous and intraventricular quinupristin/dalfopristin. Clin Neurol Neurosurg. 2002;104(1):54-6.

(148.) Ziai WC, Lewin JJ. Improving the role of intraventricular antimicrobial agents in the management of meningitis. Curr Opin Neurol. 2009;22(3):277-82.

(149.) Savitz SI, Rivlin MM, Savitz MH. The ethics of prophylactic antibiotics for neurosurgical procedures. J Med Ethics. 2002;28(6):358-63.

(150.) Attenello FJ, Garces-Ambrossi GL, Zaidi HA, Sciubba DM, Jallo GI. Hospital costs associated with shunt infections in patients receiving antibiotic-impregnated shunt catheters versus standard shunt catheters. Neurosurgery. 2010;66(2):284-9; discussion 9. DOI 10.1227/01.NEU.0000363405.12584.4D.

(151.) Eder C, Schenk S, Trifinopoulos J, Kulekci B, Kienzl M, Schildbock S, et al. Does intrawound application of vancomycin influence bone healing in spinal surgery? Eur Spine J. 2016;25(4):1021-8.

(152.) Edwards NC, Engelhart L, Casamento EM, McGirt MJ. Cost-consequence analysis of antibiotic-impregnated shunts and external ventricular drains in hydrocephalus. Journal of neurosurgery. 2015;122(1):139-47. DOI 10.1007/s00586-015-3943-9.

(153.) Eymann R, Chehab S, Strowitzki M, Steudel WI, Kiefer M. Clinical and economic consequences of antibiotic-impregnated cerebrospinal fluid shunt catheters. J Neurosurg Pediatr. 2008;1(6):444-50. DOI 10.3171/PED/2008/1/6/444.

(154.) Lonsdale DO, Udy AA, Roberts JA, Lipman J. Antibacterial therapeutic drug monitoring in cerebrospinal fluid: difficulty in achieving adequate drug concentrations. Journal of neurosurgery. 2013;118(2):297-301. DOI 10.3171/2012.10.JNS12883.

Publicado
2019-12-20
Cómo citar
García-Casallas, J. C., Blanco-Mejía, J. A., Fuentes- Barreiro, Y. V., Arciniegas-Mayorga, L. C., Arias-Cepeda, C. D., & Morales-Pardo, B. D. (2019). Prevención y tratamiento de las infecciones del sitio operatorio en neurocirugía. Estado del arte. Iatreia, 33(1), 39-58. https://doi.org/10.17533/udea.iatreia.23
Sección
Artículos de revisión